Literature DB >> 31255774

Role of angiogenesis in melanoma progression: Update on key angiogenic mechanisms and other associated components.

Woo Cheal Cho1, George Jour2, Phyu P Aung3.   

Abstract

Angiogenesis, the formation of new blood vessels from existing blood vessels, is a complex and highly regulated process that plays a role in a wide variety of physiological and pathological processes. In malignancy, angiogenesis is essential for neoplastic cells to acquire the nutrients and oxygen critical for their continued proliferation. Angiogenesis requires a sequence of well-coordinated events mediated by a number of tightly regulated interactions between pro-angiogenic factors and their corresponding receptors expressed on various vascular components (e.g., endothelial cells and pericytes) and stromal components forming the extracellular matrix. In this review, we discuss the functional roles of key growth factors and cytokines known to promote angiogenesis in cutaneous melanoma and key factors implicated in the extracellular matrix remodeling that acts synergistically with angiogenesis to promote tumor progression in melanoma, incorporating some of the most up-to-date basic science knowledge from recently published in vivo and in vitro experimental studies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Growth factors and cytokines; Melanoma progression

Mesh:

Substances:

Year:  2019        PMID: 31255774     DOI: 10.1016/j.semcancer.2019.06.015

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  13 in total

Review 1.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 2.  Urokinase plasminogen activator as an anti-metastasis target: inhibitor design principles, recent amiloride derivatives, and issues with human/mouse species selectivity.

Authors:  Nehad S El Salamouni; Benjamin J Buckley; Marie Ranson; Michael J Kelso; Haibo Yu
Journal:  Biophys Rev       Date:  2022-01-06

Review 3.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

Review 4.  Hypoxia-Induced circRNAs in Human Diseases: From Mechanisms to Potential Applications.

Authors:  Qi Huang; Juan Yang; Robby Miguel Wen-Jing Goh; Mingliang You; Lingzhi Wang; Zhaowu Ma
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

5.  Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line.

Authors:  Chaoji Shi; Ziyue Gu; Shengming Xu; Houyu Ju; Yunteng Wu; Yong Han; Jiayi Li; Chuwen Li; Jing Wu; Lizhen Wang; Jiang Li; Guoyu Zhou; Weimin Ye; Guoxin Ren; Zhiyuan Zhang; Rong Zhou
Journal:  Cancer Commun (Lond)       Date:  2022-06-04

Review 6.  Advances in Targeting Cutaneous Melanoma.

Authors:  Dimitri Kasakovski; Marina Skrygan; Thilo Gambichler; Laura Susok
Journal:  Cancers (Basel)       Date:  2021-04-26       Impact factor: 6.639

Review 7.  Hypoxia-dependent drivers of melanoma progression.

Authors:  Simona D'Aguanno; Fabiana Mallone; Donatella Del Bufalo; Antonietta Moramarco; Marco Marenco
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08

Review 8.  Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician.

Authors:  Rebecca Adams; Bernhard Moser; Sophia N Karagiannis; Katie E Lacy
Journal:  Cancers (Basel)       Date:  2021-11-10       Impact factor: 6.575

Review 9.  Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment.

Authors:  Davide Quaresmini; Michele Guida
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

10.  Lymphatic blood filling in CLEC-2-deficient mouse models.

Authors:  Elizabeth J Haining; Kate L Lowe; Surasak Wichaiyo; Raghu P Kataru; Zoltan Nagy; Dean Pj Kavanagh; Sian Lax; Ying Di; Bernhard Nieswandt; Benoît Ho-Tin-Noé; Babak J Mehrara; Yotis A Senis; Julie Rayes; Steve P Watson
Journal:  Platelets       Date:  2020-03-04       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.